Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063899
Chunk: 207

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 207
---
 we
have we have 2 full-time employees, one of whom is the CEO and the other who is engaged in general and administrative functions and who
is located in Asia. We have also engaged and may continue to engage 5 independent contracted consultants and advisors to assist us with
our operations. None of our employees are represented by a labor union or covered by a collective bargaining agreement. We have never
experienced any employment related work stoppages, and we consider our relations with our employees to be good.

<div align='center'>106</div>

Intellectual Property

The technologies underlying
our various research and development projects are the subject of various patents and patent applications claiming, in certain instances,
composition of matter and, in other instances, methods of use. Prosecution, maintenance and enforcement of these patents, as well as those
on any future protectable technologies we may acquire, are and will continue to be an important part of our strategy to develop and commercialize
novel medicines, as described in more detail below. Through entering into license agreements with their owners, we have obtained exclusive
rights to these patents, applications and related know-how in the U.S. and certain other countries to develop, manufacture and commercialize
the products using or incorporating the protected inventions that are described in this registration statement and that are expected to
contribute significant value to our business. The technologies protected by these patents may also for the basis for the development of
other products.

In addition to licensed intellectual property, our in-house science
team has been actively developing our own proprietary intellectual property. No non-provisional patent application has yet been filed
in the Company’s own name for the Lead Projects. We have, however, filed a number of provisional applications to establish earlier
filing dates for certain of our other ongoing research, the specifics of which are currently proprietary and confidential.

The U.S. patent system permits
the filing of provisional and non-provisional patent applications (i.e., a regular patent application). A non-provisional patent application
is examined by the USPTO, and can mature into a patent once the USPTO determines that the claimed invention meets the standards for patentability.
On the other hand, a provisional patent application is not examined for patentability, and automatically expires 12 months after its filing
date. As a result, a provisional patent application cannot mature into a patent.

Provisional applications are
often used, among other things, to establish an earlier filing date for a subsequent non-pro